Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Annual Cancer Report Highlights Advances, Funding Threats

Published Date: 19 Sep 2026

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

Published Date: 19 Sep 2026

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

Published Date: 19 Sep 2026

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Knowledge Hub

Oncology

Therapeutic Advances in Tumor Calcium-Signaling Modulation

Comprehensive review of therapeutic advances in tumor calcium-signaling modulation for oncology professionals.

Oncology

Cancer Metabolism as a Therapeutic Vulnerability: Targeting Metabolic Plasticity and the Tumor Microenvironment

Comprehensive review of targeting cancer metabolism and the tumor microenvironment as therapeutic vulnerabilities.

Oncology

Radiopharmaceutical Theranostics: Precision Radiation Delivered Through Molecular Targeting

Comprehensive review of radiopharmaceutical theranostics for targeted precision radiation in clinical oncology.

Oncology

Protein Degradation in Cancer: PROTACs and Targeted Degraders for Previously Difficult-to-Drug Targets

Review of PROTACs and targeted degraders for undruggable cancer targets, with clinical and mechanistic insights.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Annual Cancer Report Highlights Advances, Funding Threats

Does Telenursing Improve QOL in Breast Cancer?

Long-Term Results Favor Acalabrutinib Combo in MCL

Knowledge Hub

Therapeutic Advances in Tumor Calcium-Signaling Modulation

Cancer Metabolism as a Therapeutic Vulnerability: Targeting Metabolic Plasticity and the Tumor Microenvironment

Radiopharmaceutical Theranostics: Precision Radiation Delivered Through Molecular Targeting

Protein Degradation in Cancer: PROTACs and Targeted Degraders for Previously Difficult-to-Drug Targets

Multispecific Immune Engagers: Engineering T Cells, NK Cells and Tumor Recognition Beyond Bispecific Antibodies

Tumor Evolution Under Treatment Pressure: Real-Time Tracking of Resistance and Clonal Selection

AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Annual Cancer Report Highlights Advances, Funding Threats

Does Telenursing Improve QOL in Breast Cancer?

Long-Term Results Favor Acalabrutinib Combo in MCL

Knowledge Hub

Therapeutic Advances in Tumor Calcium-Signaling Modulation

Cancer Metabolism as a Therapeutic Vulnerability: Targeting Metabolic Plasticity and the Tumor Microenvironment

Radiopharmaceutical Theranostics: Precision Radiation Delivered Through Molecular Targeting

Protein Degradation in Cancer: PROTACs and Targeted Degraders for Previously Difficult-to-Drug Targets

Multispecific Immune Engagers: Engineering T Cells, NK Cells and Tumor Recognition Beyond Bispecific Antibodies

Tumor Evolution Under Treatment Pressure: Real-Time Tracking of Resistance and Clonal Selection

AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views